Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v3-EN
Language English English
Date Updated 2022-07-20 2022-07-01
Drug Identification Number 02381494 02381494
Brand name ACH-ALENDRONATE ACH-ALENDRONATE
Common or Proper name ALENDRONATE SODIUM ALENDRONATE SODIUM
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients ALENDRONIC ACID ALENDRONIC ACID
Strength(s) 70MG 70MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 4 4
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-06-30 2022-06-30
Estimated end date
Actual end date 2022-07-19 2022-07-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments